GlassScriptPhysician profile
Ayobami David Olaleye
NPI 1376181206
$5,600.12
in general payments reported to CMS, 2019-2025
10 companies · $2,681 in 2025
The $2,681 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.75 · 2024: $2,905 · 2025: $2,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,349 · Food and Beverage: $2,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,349.14 |
| Food and Beverage | $2,250.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,107.80 | 2024-2025 | Ruby Coil, Indigo System, Penumbra System |
| Stryker Corporation | $614.21 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $312.37 | 2024-2025 | Lifevest |
| Inari Medical, INC. | $192.38 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $95.65 | 2025 | |
| Abiomed | $86.12 | 2024 | Impella |
| Edwards Lifesciences Corporation | $83.92 | 2025 | Pascal, Sapien 3 Ultra Resilia |
| Philips North America LLC | $51.80 | 2025 | Coronary Other |
| Novartis Pharmaceuticals Corporation | $38.30 | 2023-2025 | |
| Boston Scientific Corporation | $17.57 | 2025 | Farapulse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayobami Olaleye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.